Non Alcoholic Fatty liver Disease. Other specified inflammatory liver diseases Nonalcoholic steatohepatitis (NASH)
Conditions
Interventions
Intervention 1: Nutri Liver Support 150 mg, oral, twice a dey for 2 months. Intervention 2: placebo, oral, twice a day for 2 months.
Treatment - Drugs
Placebo
Nutri Liver Support 150 mg, oral, twice a dey for 2 months
placebo, oral, twice a day for 2 months
Sponsors
Semnan University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 20 to 40 years old; patients who has white skin; patients who referred to the clinic for checkup; fatty liver is reported in sonography; agreement to be a part of the study; ALT level above 40. Exclusion criteria: patients that want to withdraw the study at any time; cirrhosis is reported in sonography; patients who are detected as Wilson, autoimmune hepatitis, viral hepatitis, alcoholic hepatitis, hemochromatosis; patients who are suffering from chronic liver disease; drug causes is to be considered for fatty liver; sensitive to drug; those who are affecting by drug side effects.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine Aminotransferase. Timepoint: before and after intervention. Method of measurement: serum.;Aspartate Aminotransferase. Timepoint: before and after intervention. Method of measurement: serum. | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of serum cholesterol. Timepoint: before and after intervention. Method of measurement: serum.;Level of serum Triglyceride. Timepoint: Before & after intervention. Method of measurement: Serum.;Low-density Lipoprotein. Timepoint: Before & after intervention. Method of measurement: Serum.;High-density Lipoprotein. Timepoint: Before & after intervention. Method of measurement: Serum. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Reza Dabiri
Semnan University of Medical Sciences
Outcome results
None listed